Full Text
HE3 ANALYSIS OF AN AFFORDABLE PRICE FOR PERFORMANCE-BASED RISK SHARING SCHEME- OMALIZUMAB ADAPTATION IN KOREA

Abstract

Authors

S Kim J Kim C Kim K Shin K Kim H Kim

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×